vs
Side-by-side financial comparison of MEDALLION FINANCIAL CORP (MFIN) and Vanda Pharmaceuticals Inc. (VNDA). Click either name above to swap in a different company.
MEDALLION FINANCIAL CORP is the larger business by last-quarter revenue ($70.6M vs $57.2M, roughly 1.2× Vanda Pharmaceuticals Inc.). MEDALLION FINANCIAL CORP runs the higher net margin — 17.3% vs -246.8%, a 264.0% gap on every dollar of revenue. On growth, MEDALLION FINANCIAL CORP posted the faster year-over-year revenue change (25.4% vs 7.6%). Over the past eight quarters, MEDALLION FINANCIAL CORP's revenue compounded faster (15.0% CAGR vs 9.8%).
Mahindra & Mahindra Financial Services Limited (MMFSL) is an Indian rural non-banking financial company headquartered in Mumbai. It is amongst the top tractor financers in India, with 1000+ offices across the country.
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for central nervous system disorders. Its key marketed products cover indications including sleep-wake cycle disturbances and schizophrenia, with core operations and primary sales markets concentrated in North America, catering to patient groups with significant unmet medical needs.
MFIN vs VNDA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $70.6M | $57.2M |
| Net Profit | $12.2M | $-141.2M |
| Gross Margin | — | — |
| Operating Margin | 29.3% | -70.5% |
| Net Margin | 17.3% | -246.8% |
| Revenue YoY | 25.4% | 7.6% |
| Net Profit YoY | 20.3% | -2774.3% |
| EPS (diluted) | $0.50 | $-2.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $70.6M | $57.2M | ||
| Q3 25 | $58.7M | $56.3M | ||
| Q2 25 | $62.6M | $52.6M | ||
| Q1 25 | $63.0M | $50.0M | ||
| Q4 24 | $56.3M | $53.2M | ||
| Q3 24 | $53.3M | $47.7M | ||
| Q2 24 | $51.0M | $50.5M | ||
| Q1 24 | $53.3M | $47.5M |
| Q4 25 | $12.2M | $-141.2M | ||
| Q3 25 | $7.8M | $-22.6M | ||
| Q2 25 | $11.1M | $-27.2M | ||
| Q1 25 | $12.0M | $-29.5M | ||
| Q4 24 | $10.1M | $-4.9M | ||
| Q3 24 | $8.6M | $-5.3M | ||
| Q2 24 | $7.1M | $-4.5M | ||
| Q1 24 | $10.0M | $-4.1M |
| Q4 25 | 29.3% | -70.5% | ||
| Q3 25 | 33.2% | -55.6% | ||
| Q2 25 | 31.1% | -73.2% | ||
| Q1 25 | 32.1% | -82.0% | ||
| Q4 24 | 32.8% | -19.3% | ||
| Q3 24 | 26.6% | -23.1% | ||
| Q2 24 | 24.3% | -20.1% | ||
| Q1 24 | 33.6% | -19.5% |
| Q4 25 | 17.3% | -246.8% | ||
| Q3 25 | 13.2% | -40.1% | ||
| Q2 25 | 17.7% | -51.7% | ||
| Q1 25 | 19.1% | -58.9% | ||
| Q4 24 | 18.0% | -9.2% | ||
| Q3 24 | 16.1% | -11.2% | ||
| Q2 24 | 13.9% | -9.0% | ||
| Q1 24 | 18.8% | -8.7% |
| Q4 25 | $0.50 | $-2.40 | ||
| Q3 25 | $0.32 | $-0.38 | ||
| Q2 25 | $0.46 | $-0.46 | ||
| Q1 25 | $0.50 | $-0.50 | ||
| Q4 24 | $0.43 | $-0.09 | ||
| Q3 24 | $0.37 | $-0.09 | ||
| Q2 24 | $0.30 | $-0.08 | ||
| Q1 24 | $0.42 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $136.3M | $84.9M |
| Total DebtLower is stronger | $216.0M | — |
| Stockholders' EquityBook value | $408.6M | $327.2M |
| Total Assets | $3.0B | $488.9M |
| Debt / EquityLower = less leverage | 0.53× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $136.3M | $84.9M | ||
| Q3 25 | $72.5M | $70.0M | ||
| Q2 25 | $110.4M | $81.0M | ||
| Q1 25 | $131.5M | $111.8M | ||
| Q4 24 | $98.2M | $102.3M | ||
| Q3 24 | $120.6M | $100.5M | ||
| Q2 24 | $87.7M | $103.0M | ||
| Q1 24 | $54.8M | $125.2M |
| Q4 25 | $216.0M | — | ||
| Q3 25 | $215.7M | — | ||
| Q2 25 | $199.9M | — | ||
| Q1 25 | $199.7M | — | ||
| Q4 24 | $232.2M | — | ||
| Q3 24 | $232.0M | — | ||
| Q2 24 | $230.8M | — | ||
| Q1 24 | $225.6M | — |
| Q4 25 | $408.6M | $327.2M | ||
| Q3 25 | $397.4M | $466.0M | ||
| Q2 25 | $389.9M | $486.3M | ||
| Q1 25 | $380.2M | $511.4M | ||
| Q4 24 | $370.2M | $538.5M | ||
| Q3 24 | $362.4M | $541.2M | ||
| Q2 24 | $354.0M | $542.5M | ||
| Q1 24 | $349.0M | $544.0M |
| Q4 25 | $3.0B | $488.9M | ||
| Q3 25 | $2.9B | $601.1M | ||
| Q2 25 | $2.9B | $624.7M | ||
| Q1 25 | $2.8B | $631.9M | ||
| Q4 24 | $2.9B | $656.2M | ||
| Q3 24 | $2.9B | $645.1M | ||
| Q2 24 | $2.8B | $651.4M | ||
| Q1 24 | $2.6B | $652.7M |
| Q4 25 | 0.53× | — | ||
| Q3 25 | 0.54× | — | ||
| Q2 25 | 0.51× | — | ||
| Q1 25 | 0.53× | — | ||
| Q4 24 | 0.63× | — | ||
| Q3 24 | 0.64× | — | ||
| Q2 24 | 0.65× | — | ||
| Q1 24 | 0.65× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $126.3M | $-29.4M |
| Free Cash FlowOCF − Capex | — | $-29.5M |
| FCF MarginFCF / Revenue | — | -51.6% |
| Capex IntensityCapex / Revenue | — | 0.2% |
| Cash ConversionOCF / Net Profit | 10.35× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-110.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $126.3M | $-29.4M | ||
| Q3 25 | $67.0M | $-31.6M | ||
| Q2 25 | $-10.7M | $-15.3M | ||
| Q1 25 | $36.3M | $-33.1M | ||
| Q4 24 | $108.7M | $-1.8M | ||
| Q3 24 | $24.6M | $-14.6M | ||
| Q2 24 | $27.6M | $-6.9M | ||
| Q1 24 | $32.3M | $7.6M |
| Q4 25 | — | $-29.5M | ||
| Q3 25 | — | $-31.8M | ||
| Q2 25 | — | $-15.6M | ||
| Q1 25 | — | $-33.6M | ||
| Q4 24 | — | $-2.0M | ||
| Q3 24 | — | $-14.7M | ||
| Q2 24 | — | $-7.0M | ||
| Q1 24 | — | $7.6M |
| Q4 25 | — | -51.6% | ||
| Q3 25 | — | -56.5% | ||
| Q2 25 | — | -29.6% | ||
| Q1 25 | — | -67.1% | ||
| Q4 24 | — | -3.8% | ||
| Q3 24 | — | -30.9% | ||
| Q2 24 | — | -13.9% | ||
| Q1 24 | — | 15.9% |
| Q4 25 | — | 0.2% | ||
| Q3 25 | — | 0.3% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | 0.9% | ||
| Q4 24 | — | 0.4% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | 10.35× | — | ||
| Q3 25 | 8.63× | — | ||
| Q2 25 | -0.97× | — | ||
| Q1 25 | 3.02× | — | ||
| Q4 24 | 10.72× | — | ||
| Q3 24 | 2.86× | — | ||
| Q2 24 | 3.89× | — | ||
| Q1 24 | 3.22× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MFIN
Segment breakdown not available.
VNDA
| Fanapt | $33.2M | 58% |
| Hetlioz | $16.4M | 29% |
| PONVORY | $7.6M | 13% |
